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EDITORIAL REVIEW
Kinetic modeling of hemodialysis, hemofiltration,
and hemodiafiltration
The principle underlying all methods of blood purification for
the treatment of uremia is based on the assumption that most
symptoms of uremia depend on the concentrations of dialysable
substances which are the end products of metabolism normally
eliminated by the kidney. Therefore, dialysis therapy can only
be effective if the concentrations of these endogenous sub-
stances remain below toxic limits.
In the last 10 years, diverse guidelines have been suggested
for optimal treatment of uremic patients [1—6]. Common to
them all is the endeavor to standardize dialysis therapy by
systematically establishing the connection between the concen-
trations of certain substances and the length of treatment.
Concentrations of urea or creatinine in plasma or urine of the
calculated clearance of certain marker substances are used to
indicate the adequacy of treatment. The treatment schedule is
chosen so that concentrations remain within a given range, or
_________
so that a particular volume of blood is cleared of toxin each
week [7—1 11. The best known models are the "dialysis index"
[2, 3] and the so-called kinetic or pooi models. We will focus our
attention on the latter models.
Kinetic models allow the prediction and control of the
concentrations of substances during and between treatments.
Moreover, multiple pool models can predict changes in body
compartments normally inaccessible to the clinician but none-
theless may be relevant to clinical side effects. However, the
compartment volumes and intercompartmental transfer and
distribution coefficients vary from one patient to another and
between treatments and are not readily accessible, thus detract-
ing from the routine use of such models for the estimation of
required treatment times. If clinical symptoms are caused by
"disequilibrium" between body compartments, they are unlike-
ly to be alleviated without the use of multiple pool models.
The mathematical definition and the ability to measure the
variables which influence solute concentrations and distribution
are essential requirements for the use of kinetic models. These
include: (1) dialyser clearance; (2) residual renal clearance; (3)
the rate and location of generation of the substance in question;
(4) compartment volumes, intercompartmental transfer and
distribution coefficients. Each of these variables will be treated
separately.
Variables in kinetic modeling
Dialyzer clearance (K). The dialyzer clearance determines
the removal rate of a substance from blood and does not only
depend on the characteristics of the dialyzer but also on the
nature of the treatment method.
In all methods (hemodialysis, hemofiltration, or hemodiafil-
tration), dialysis clearance K can be calculated by means of the
mass balance equation:
(1)
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Here, K represents clearance (mllmin), QBI and QB0 repre-
sent blood flow at the inlet and outlet of the dialyzer, and CBI
and CBO corresponding concentrations of the substance in
question (mmoles/liter). If QF is the ultrafiltration rate, then
QB0 = QBI QF. (2)
Henceforth, blood flow will be defined by QB = QBI, and QBO
is eliminated from equation (1) by substitution of equation (2).
This leads to a general clearance formula which can be applied
to all three methods (hemodialysis, hemofiltration, and
hemodiafiltration):
CBI — CB0 CB0KKHDFKHDKHFQB
L.Bi
(QB — QF) CBI—CBO + QF. (3)
It is often assumed, particularly in hemodiafiltration, that the
first terms of equation (3) describe the effect of diffusion and the
second that of convection [12]. We find that this division into
components is incorrect, because CB0 depends on both the
diffusion and convection components, which occur
simultaneously.
In hemofiltration (pure), the removal rate of substance
through the filter can be measured in the filtrate. Thus equation
(1) can be replaced by KHF CB = QF CF, C representing the
concentration in the filtrate (mmoles/liter). This results in a
special clearance equation for hemofiltration:
KHF = Qi. (4)
In hemodialysis we have (approximately) QF = 0, and
equation (3) reduces to the familiar formula [9, 13]:
KHD = QB CBI
CBI
(5)
This dialyzer clearance is considered to be constant during
hemodialysis under unchanged operating conditions (blood and
dialysate flow). This assumption is approximately true only for
high flux dialyzers and machines with controlled ultrafiltration.
But these conditions are not always fulfilled in the literature.
KC8, = Qth CBI — Qs0 CBO.
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Fig. 1. Progress of average filtration rates (QF) during hemodiafiltra-
tion treatments lasting 3 to 4 hr in three of six patients. The measured
filtration rates of the six patients are summarized in Table 1. In all
patients the filtration rate changes substantially, particularly in the first
30 mm. It decreased on an average by 30.6%, from 84 mI/mm in the first
5 mm to 58 mI/mm after 3.5 hr. The points of measurement lie on an
exponential curve described by a function of the type y = A + i3e".
Differences in the rate of decrease of filtration rate between patients
(curves I to 3) may be attributed to differences in blood composition
(hematocrit, concentration of fat, albumen, and fibrinogen). Symbols are:
A, markers of curve 1; •, markers of curve 2; •, markers of curve 3.
In hemodiafiltration (HDF), that is, a simultaneous hemofil-
tration/hemodialysis [14, 15], however, the clearance decreases
significantly during treatment, as our own in vivo measure-
ments have shown. This is caused by a decrease of the filtration
rate and of the sieving coefficient. The observed decrease in
filtration rate during hemodiafiltration (Fig. 1, Table 1)' is
probably caused by a protein gel layer of "secondary mem-
brane" forming on the surface of the dialyzer membrane at a
rate dependent upon the filtration rate and in turn causing an
increasing resistance to filtration [16]. A steady state may occur
when the rate of deposition is balanced by the rate of removal
by diffusion and penetration through the membrane [17]. How-
ever, the sieving coefficient also decreases with protein deposi-
tion and mass transport is further reduced. This was investigat-
ed for several substances at the beginning and at the end (after 4
hr) of six hemodiafiltration treatments for the RP 6 dialyzer
under standard conditions (QB = 200 mllmin, TMP = 500 mm
Hg, QD = 0 mllmin). The decrease of sieving coefficient was
significant for creatinine (15%), glucose (9%), phosphate (17%),
and inulin (22%) but not for urea (unpublished data). The
reduction of filtrate flow and sieving coefficient causes a
patient-specific reduction of the total clearance of urea and
creatinine by about 10 to 15% in HDF (Figs. 2 and 3, Table 2).
For the kinetic modeling of hemodiafiltration, it is therefore
'Six patients were hemodiafiltered in postdilution mode 50 times
each; filtrate was collected continuously in 30-mm periods. The average
volume of substitution solution was 10.5 2 liters per treatment. Blood
flow (250 mI/mm), dialysate flow (500 mI/mm), and transmembrane
pressure (513 12 mm Hg) were maintained at constant levels during
all treatments. At the beginning, after 30 mm, 30 mm before the end,
and at the end of six consecutive treatments heparinized blood samples
were taken at the arterial and venous parts of the dialyzer (RP6). Urea
and creatinine concentrations were determined by routine methods.
Also, urea and creatinine concentrations were measured 45 and 90 mm
after the end of three consecutive HDF and in the intertreatment
interval to cover the course of the concentration during the interval. See
the legend of Figure 1 for the progress of average filtration rates during
hemodiafiltration treatments in three of the six patients.
.Time
mm
Filtration rate, mi/mm
(1) (2) (3) 4 5 6
0 84.09 83.46 83.31 80.27 85.89 84.97
30 71.30 70.90 70.80 65.02 75.49 76.42
60 68.49 67.73 66.84 60.29 72.94 70.63
90 66.90 66.95 65.21 56.96 71.02 66.03
120 66.07 65.52 62.09 53.89 68.84 62.49
150 65.22 64.05 59.62 51.28 68.64 58.74
180 63.48 61.46 59.90 50.62 66.90 57.13
210 62.68 58.33 50.02 64.50 54.82
240 61.40
y = A + l3e'
a —5.6 —4.5 —2.8 —4.6 —4.4 —1.6
3 20.8 22.0 30.7 30.2 19.8 41.4
A 84.09 83.46 83.31 80.27 85.89 84.97
a These numbers represent the mean values SD of N = 50 measured
data; Table I supplements Figure 1.
recommended that dialyzer clearance should be determined
again for each patient, because the changes in plasma concen-
trations can be predicted only for an individual dialysis treat-
ment if the clearance is known as a function of time.
These results imply that even in hemodialysis the ultrafiltra-
tion rate may influence dialyzer clearance. As a rule, only low
ultrafiltration rates (5 to 15 mllmin) are necessary to attain the
required weight loss and this increases the clearance of small
molecules such as urea only slightly (3 to 10%) but can increase
the clearances of middle molecules such as inulin by 30 to 40%.
A small drop in the ultrafiltration rate during hemodialysis may
therefore cause a significant reduction in middle molecule
clearance. This effect may be diminished by devices that
maintain a constant ultrafiltration rate rather than a constant
transmembrane pressure.
Residual renal clearance (KR). The effects of even very low
residual renal clearances (1 to 2 mllmin) should not be underes-
timated for the calculation of substance concentrations in
dialysis patients because the natural kidney functions continu-
ously and can significantly affect blood concentrations [18],
particularly in the middle molecular weight range (500 to 5000
daltons). Care should be exercised because an error of 1/2
ml/min when measuring a clearance of 1 ml/min can lead to
errors of 10 to 12% in the weekly middle molecule clearance if
the clearance during dialysis is 20 mllmin [23]. The main
sources of error are: the difficulty in passing small volumes of
urine and the change in plasma creatinine concentration be-
tween dialysis treatments.
Errors can be minimized by the collection of urine over a
period substantially longer than the usual 24 hr and taking blood
samples at the beginning and the end of urine collection and
using the average.
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Figs. 2 (left) and 3 (right). Average urea and creatinine clearance (N = 6) of three patients (Table 2) plotted against time during hemodiafiltration
treatments lasting 4 hr. Urea and creatinine clearance of the four sample points were calculated by means of equation [3]. Then clearance as a
function of time was calculated connecting these points by a spline function.
A convenient method is to collect urine samples during an
entire interdialytic interval so that arterial blood samples post-
and predialysis can be used. Urine collection begins immediate-
ly following dialysis after the emptying of the bladder and ends
with the collection of the urine at the final emptying of the
bladder before the subsequent treatment. The volume of urine
(Va) and urine concentration (Ce) are measured, and residual
renal clearance is calculated using
—
2CxV0KR —
(C0 + C) X t
where t is the duration of collection (that is, interdialytic
interval) and C0 and C refer to plasma concentrations at the
beginning and end of collection.
We assume that plasma concentrations increase linearly and
the small nonlinear "rebound" which occurs after dialysis is
negligible.
Generation rate. The synthesis of toxic substances can in
effect take place in either the intra- or extracellular compart-
ments [13, 19]. For example urea is the end product of protein
catabolism in the liver which represents a small proportion of
body tissue and can therefore be considered extracellular with
respect to the majority of cells. Nevertheless, an intracellular
pool generation is generally assumed in the literature [21, 22].
Creatinine, on the other hand, is produced intracellularly in
muscle which represents the bulk of body mass and therefore is
considered to be generated in the intracellular compartment [19,
20]. If a single pooi model is assumed and the volume, residual
renal clearance, and generation rate are assumed to be con-
stant, the latter can be estimated from the rise in plasma
concentration between treatments:
Cb(t) — Cb(0)G=Vx +KRXc:bt (7)
where Cb is the mean value of Cb (T) during the period from 0 to
t, and a good estimate of Cb is given by 1/2 [Cb (0) + Cb (t)].
In this formula V represents the distribution volume in
milliliters; Cb (0) and Cb (t) are plasma concentrations at the
beginning and end of the measurement period (t). To prevent
rebound from affecting the measurement of G the first blood
sample can be taken a few hours after the end of dialysis.
Compartment volumes, mass transfer, and distribution coef-
ficients: Compartment volumes (V). Various multiple pool models
Patient0b Substance
Time, mm
0 30 150 180 210 240
1 U
C
167
148
162
142
155
135
155
134
2 U
C
162
143
156
137
150
129
148
127
3 U
C
152
136
146
129
138
121
139
121
4 U
C
152
136
140
127
130
118
129
117
5 U
C
166
152
156
147
ISO
141
147
138
6 U
C
170
146
158
140
145
129
141
125
have been constructed in accordance with physiological
measurements of body compartment volumes usually in pa-
tients with normally functioning kidneys [21, 23—30]. Popovich
Ct al [30] estimated the volumes of the intracellular, intravascu-
lar, and interstitial compartments and the coefficients of mass
transfer between these compartments by using a three-pool
model to analyze the dilution curves after bolus injection of
radioisotope labelled substances in an anephric patient between
dialysis treatments. The results show mass transfer coefficients
E
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Table 2.a
(6)
Abbreviations: U, urea; C, creatinine,
a The data represent mean values sn of six measurements; dialyzer
clearance (K) has been measured in milliliters per minute.
b The curves of Figures 2 and 3 are calculated with the data of
patients 1 to 3 shown here.
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and interstitial volumes which decrease when molecular weight
increases. Popovich et al [301 attributes the latter to the
omission from the model of "flow limitations." Schindhelm and
Farrell [24] repeated this method using fixed volumes from
physiological literature rather than attempting to fit both vol-
umes and mass transfer coefficients to one set of data. This
resulted in a much higher estimate of transcellular mass transfer
coefficients. It is not yet clear from available data whether the
use of a multiple pool model with variable volume comes closer
to reality for the prediction of mass transport than those with
fixed volume.
Mass transfer coefficients (T). A series of measurements of
blood concentrations during dialysis or immediately after dialy-
sis can be used to determine the distribution of a substance in
the body and the concomitant transfer resistance to transport
between the compartments [30].
During treatment the high dialyzer clearance causes an im-
balance between concentrations in the intra- and extracellular
compartments. The rapid decrease in plasma concentration
leads to a considerably slower drop in intracellular concentra-
tion, since only a small proportion of substance passes over
from the intracellular to the extracellular space during dialysis.
This results in an accelerated renewed increase of plasma
concentration after dialysis. This increase is referred to as
"rebound" and can be used to calculate the cell membrane
mass transfer coefficient [21, 30]. The magnitude of disequilibri-
um and rebound are higher when the mass transfer coefficient is
low (as is the case for middle molecules). Measurements of
transcellular transfer coefficients for urea, creatinine, and vita-
min B12 have been reported by several authors [19, 21, 22, 24—
26, 28—31]. However the urea rebound may not be caused
exclusively by transcellular disequilibrium but may be affected
by an increase in protein catabolism induced by loss of glucose
and aminoacids [24]. This would make the transfer resistance
seem larger than it actually is.
For all the solutes studied the transcapillary transfer coeffi-
cients are at least an order of magnitude higher than the
transcellular transfer coefficients. The latter must therefore be
the limiting factor in mass transport.
Distribution coefficients (x). The distribution coefficient (x) is
the ratio of concentrations of the substance in two compart-
ments at equilibrium. Dombeck, Klein, and Wendt [29] report-
ed the best fit of calculated to measured creatinine data using x
= 1.63 between the intracellular and extracellular compart-
ment, which was the value previously measured by Giovanetti
and Barsotti [32]. Although reduction of x to 1.0, which is
usually assumed in the literature for distribution of all sub-
stances between the intracellular volume (ICV) and extracellu-
lar volume (ECV), had little effect on the mass transfer coeffi-
cient, it affected the generation rate and the dialyzer clearance
substantially. The latter is thereby diminished to values which
clearly lie under the measured in vivo clearance values [29].
Distribution coefficients for urea, creatinine, and inulin be-
tween red cells and plasma have been reported as 0.86, 0.73,
and 0.0, respectively [33]. The distribution coefficient is equal
to 0 for substances which cannot penetrate into the red cells,
while the distribution coefficient is equal to 1 if the concentra-
tion is equal in both compartments. However, more recent
measurements [34] on uremic erythrocytes could not detect a
significant difference between plasma and red cell concentra-
tions of urea and creatinine, so that their distribution coeffi-
cients may be ignored in pool calculations.
Kinetic modeling
Compartmental kinetic models may be used with differential
equations to simulate the rates of changes in concentrations of
solutes in the various compartments (or fluid pools) of dialysis
patients. Given a starting point ("infinitral condition") the
differential equations can be solved, such as on a computer
using numerical methods, for example, the Runge-Kutta meth-
od, to predict changes in the variables, for example, concentra-
tions. Reliable prediction of the probable course and results of
therapy is, however, only possible when sufficient information
on the past and present condition of the patient is available. If
this is the case, the model can, for example, be used to obtain
"optimal therapy."
To our present knowledge, a pool model that supplies long-
term predictions does not exist [1, 9, 13, 19, 21, 22, 24—27, 29—
31, 35—40]. It is doubtful whether a suitable model can be
developed for such a diverse group as that of dialysis patients.
Human physiology is complex and the more realistic models
require too many data for general application to individual
patients. Furthermore, small errors in the received data of the
variables can generate accumulative errors in long-term predic-
tions. Thus, models should be divided into at least two distinct
types depending on the desired application namely: (I) models
which are used primarily as research tools to check the quanti-
tative validity of proposed physiological mechanisms and (2)
models which can be applied in routine clinical practice or for
designing protocols to test new techniques or equipment. The
latter requires particularly simple models with a minimum of
variables to be measured and processed, but a reasonable
degree of accuracy is necessary to predict overall mass balance
(that is, pre- and postdialysis concentrations). The research
models, on the other hand, can be considerably more complex
and may be valid as broad generalizations of the system rather
than being applied quantitatively to individual patients. It is,
however, often necessary to limit the number of variables
because of the difficulty in making measurements, unless ex-
trapolation from minimal data is considered acceptable. This is
often a necessary expedient.
The single pooi model. In the past, the one-pool model has
been applied most frequently to dialysis-related techniques, not
only to simulate the overall mass balance of small molecules,
but also for middle molecules such as inulin [1, 38].
In the single pool model, the body of the patient is conceived
as a homogenous compartment or "pool" of fluid in which all
substances are uniformly distributed. The distribution volume
should correspond to the total body water [24—28].
The rate of change of the quantity of a substance in the pool
(V), that is, !. Cb (t), during treatment can then be calculated
from the dialyzer clearance (K), substance concentration (Cb),
residual renal clearance (KR), and the generation rate (G) of the
substance according to the following general model equation [41]:
[V (t) x Cb (t)] = —K(t) Cb(t) — KR Cb(t) + G. (8)
If the initial concentration and time intervals [and, of course,
the variables V(t), K(t), KR, G] are known, then this equation
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Figs. 4 (left) and 5 (right). Kinetics of urea and creatinine during hemodiafiltration and in the following interval, simulated by the one pooi model
(curve C) and two pooi model (curve B, intravascular compartment; curve A, intracellular compartment). The measured plasma concentrations of
urea and creatinine are marked.
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Table 3.
Variable factors Fig. 4 Figs. 5 and 6
Dialyzer clearance K, ml/min
0 mm 154 140
30 mm 148 134
180 mm 140 125
210 mm 137 122
Residual renal clearance KR, mI/mm 0 0
Total body volume V(L) = 0.57 x kg [24, 25] 42.75 34.8
Intracellular V1 = ¾ V [29]
Extracellular V2 = 1/3 V [29]
Mass transfer coefficient T, ml/minb
Urea 700
Creatinine 150
Distribution coefficient X 1 1
Generation rate G, p.moleslminc 136 5.01
Extracellular G2 = 0
Intracellular G, = G
a From these data K was calculated as a function of time (spline-
function) as mentioned earlier.
b T was chosen, such that the theoretical curve, calculated from the
model, fits the measured data. (They correlate with values from [19, 22,
28—301.)
For the calculation of G the rebound effect was eliminated by using
the measurements 1.5 and 3 hr after HDF, respectively, as the initial
concentration.
can be used to predict the actual time course of the concentra-
tion changes, for example, pre- and postdialysis concentrations
in plasma [3, 7—11, 13, 20, 23, 35, 37, 39, 421. But this model
does not simulate the interdialytic period precisely. Before the
beginning of the next treatment a clear difference exists be-
tween measured and calculated values. This discrepancy is
caused by the rebound of urea and creatinine after treatment
(as, for example, after hemodiafiltration in Figs. 4 and 5, Tables
4 to 9). In the clinical application of the single pool model it is
normal practice to adjust G until the model fits the observed
Table 4. Patient no. 1: Hemodiafiltration (HDF): 3 x 240 mm/week
residual renal clearance: 0 mI/mm: dry body weight, 62.0 kg
Day HDF
Time
mm
Urea
mmoleslliter
Creatinine
mmoles/liter
Filtration
rate
mI/mm
1 1
1
1
1
0
30
210
240
285
330
29.5
25.0
13.3
12.8
13.2
14.3
1.45
1.17
0.83
0.70
0.84
0.85
84
71
60
57
2 1390 17.1 1.09
3 2
2
2
2
2870
2900
3080
3110
3155
3200
23.3
19.5
12.5
12.0
12.2
12.5
1.30
1.08
0.73
0.71
0.76
0.81
85
68
63
55
4 4350 16.9 1.04
5 3
3
3
3
5745
5775
5955
5985
6030
6075
23.6
21.2
11.2
10.3
11.7
13.2
1.23
1.02
0.65
0.64
0.72
0.76
90
68
58
54
6 7525 16.5 1.01
7 8620 23.3 1.24
8 4
4
10110
10140
28.2
25.0
1.34
1.20
88
68
data. Such a model is capable of predicting concentration
changes over several treatments, but the results presented here
illustrate that fitted values of G may not be physiologically
realistic. That is particularly true for creatinine where the
rebound shown by the two pool model (see below) is large.
Although the error caused by rebound when a single pooi model
1.2
1.1
Curve A
Curve B
C,
Q.10
E
: tO
0.9
0
C 0.80
0.7C
0C0
C)
Curve A
Curve B
Curve C
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Day HDF
Time
mm
Urea
mmoleslliter
Creatinine
mmo/es//iter
Filtration
rate
mi/mm
1 1
1
1
1
0
30
170
210
255
300
30.6
25.2
18.9
17.8
18.5
18.9
1.48
1.18
0.88
0.85
0.92
0.96
92
70
62
58
2 1250 20.3 1.16
3 2
2
2
2
2875
2905
3045
3075
3120
3165
25.3
22.6
15.2
14.3
14.5
15.0
1.32
1.11
0.80
0.76
0.86
0.87
90
70
60
60
4 3890 19.2 LOS
5 3
3
3
3
5760
5790
5930
5960
6005
6050
24.4
20.6
14.4
14.0
14.2
14.7
1.25
1.08
0.77
0.72
0.80
0.92
89
68
61
60
6 6970 18.7 1.00
7 8495 24.5 1.19
8 4
4
10195
10215
30.5
25.9
1.42
1.13
88
71
is used for urea is relatively small [13, 20, 21]; it can be as high
as 50% for middle molecules [30].
The two pooi model. In the two pool model, the total body
water volume (V) is divided into two homogeneous compart-
ments: the intracellular volume (ICY V1) and the extracellu-
lar volume (ECV = V2). The concentrations in these compart-
ments are denoted by Cb and Cb2, respectively, and the intra- to
extracellular mass transfer coefficient (T) and the distribution
coefficient (X) must also be known. The general differential
equations describing the two pool model with constant volumes
are:
Cb(t) = -(—TCb(t) + XTCb,(t) + G1)
C2(t) = +(TCb(t) — (XI + K(t) +
KR) Cb2(t) + G2)
where G1 and G2 are the generation rates in compartments V1
and V2. Usually the following assumptions are made:
• V1, V2, T, X, KR, G1, and G2 are constant
• No significant protein binding occurs
• Pools are homogenous — even during dialysis
Day HDF
Time
mm
Urea
mmoles/iiter
Creatinine
mmoies/iiter
Filtration
rate
mi/mm
1 1
1
1
1
0
30
130
180
225
270
31.3
26.6
20.8
19.8
20.4
20.7
1.35
1.17
0.97
0.94
1.00
1.02
87
72
62
58
2 1270 23.1 1.12
3 2
2
2
2
2865
2895
2995
3025
3070
3115
25.0
21.8
16.3
15.5
16.8
17.8
1.25
1.03
0.84
0.83
0.89
0.90
90
88
62
59
4 3965 19.3 1.07
5 3
3
3
3
5750
5780
5880
5910
5955
6000
23.4
21.2
15.9
14.8
15.4
15.8
1.20
1.07
0.86
0.80
0.84
0.89
90
71
62
56
6 6965 18.0 1.02
7 8375 23.7 1.13
8 4
4
10115
10145
31.1
29.9
1.25
1.06
90
83
• Mass transfer of solutes between compartments (in accord-
ance with coefficients T and X) is linear
• Solute generation only takes place in the intracellular pool.
Errors may result if any of these assumptions are incorrect. The
equations for the two pool model can be solved explicitly [41] if
the variables are constant or, as in the instance cited below on a
computer using numerical methods, using, for example, the
Runge-Kutta method [41]. The interdialytic interval, including
the rebound, is of course simulated by using K = 0. The initial
plasma concentration is easily measured but the intracellular
concentration must be estimated from the distribution coeffi-
cient Cb = XCb2. As the one pooi model simulations had only
given an imprecise description of urea and creatinine kinetics in
hemodiafiltration patients, we attempted a better evaluation of
the measurements obtained with a two pool model. In the
application of the one and two pool models the following data
for the variable factors were used (Table 3).
It can be seen in our Figures 4 and 5 that the two pool model
(10) simulates the observed data more accurately than the single
pool model, particularly with regard to the creatinine rebound.
This becomes especially clear if the process is followed over
two treatment intervals such as creatinine concentration in
Figure 6 (Tables 4 to 9). The urea rebound is smaller and of
shorter duration and so the difference between the two models
is less significant.
Table 5. Patient no. 2: Hemodiafiltration (HDF): 3 X 210 mm/week
residual renal clearance: 1.0 ml/min; dry body weight, 62.5 kg
Table 6. Patient no. 3: Hemodiafiltration (HDF): 3 >< 180 mm/week
residual renal clearance: 2.9 mI/mm; dry body weight, 86.0 kg
(9)
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Table 7. Patient no. 4: Hemodiafiltration (HDF): 3 x 210 mm/week
residual renal clearance: 0.4 mI/mm; dry body weight, 64.5 kg
Day HDF
Time
mm
Urea
mmoles/liter
Creatinine
mmoles/liter
Filtration
rate
mi/mm
1 1
1
1
1
0
30
170
210
255
300
31.6
26.1
18.5
17.5
18.0
18.3
1.59
1.34
0.99
0.93
1.00
1.05
87
66
50
48
2 1330 22.6 1.25
3 2
2
2
2
2915
2945
3085
3115
3160
3205
28.5
24.8
16.0
15.5
15.8
16.3
1.42
1.21
0.85
0.80
0.88
0.90
85
72
50
50
4 4005 18.2 1.08
5 3
3
3
3
5705
5735
5875
5905
5950
5995
24.2
19.2
12.5
12.2
12.8
13.2
1.23
1.02
0.75
0.73
0.78
0.83
89
65
48
48
6 7095 18.0 1.05
7 8545 21.8 1.22
8 4
4
10085
10115
28.7
23.7
1.39
1.19
88
65
Multiple pooi models. Some authors have checked the valid-
ity of the two pool model by looking for further improvements
after subdividing the intra- and extracellular compartments [24,
25, 30, 31]. Multiple pool models attempt to reproduce as
realistically as possible the kinetics of solute transport during
and between treatments. To do this, as many kinetic data as are
available are used. However, the requirement for data limits the
usefulness of multiple pool models because most of the new
variables cannot be measured directly in humans and with
every additional compartment several new variables and con-
stants are introduced. While the single pool model has disad-
vantages caused by the omission of transport across cell
membranes, the addition of this factor requires the estimation
of the mass transfer coefficient, Further extension requires the
extraction of more information from essentially the same data
and this becomes susceptible to experimental error. Further-
more, it is difficult to determine whether these subtle differ-
ences in the raw data actually represent the physiological
processes built into the models.
These problems have prevented the widespread use of mull i-
ple pool models. In practice one must therefore choose between
simple models, which only define reality in a limited fashion,
and complex models which demand the collection of large
quantities of precise data with corresponding expense in effort.
Table 8. Patient no. 5: Hemodiafiltration (HDF): 3 x 210 mm/week
residual renal clearance: 0 mI/mm; dry body weight, 75.0 kg
Day HDF
Time
mm
Urea
mmoles/liter
Creatinine
mmoles/liter
Filtration
rate
mi/mm Fig.
1 1
1
1
1
0
30
120
180
210
390
570
730
30.3
28.2
21.6
19.1
15.7
19.4
20.5
20.7
1.28
1.05
0.91
0.82
0.73
0.88
0.89
0.90
80
75
65
62
2 1525
2170
22.1
28.2
1.02
1.11
3 2
2
2
2
2
2870
2900
2990
3050
3080
3260
3440
3620
28.7
23.7
18.9
15.9
13.6
14.4
15.5
16.9
1.15
0.96
0.78
0.75
0.63
0.74
0.78
0.83
80 1'
74
64
60
4 4310
5090
17.6
21.2
0.92
0.98
5 3
3
3
3
3
5770
5800
5890
5950
5980
6160
6340
6520
23.0
20.1
18.0
13.2
11.4
12.5
13.9
14.8
1.05
0.98
0.74
0.68
0.60
0.69
0.74
0.78
82
77
67
63
6 7280
7935
16.2
21.0
0.88
1.03
7 8720
9365
22.8
24.2
1.05
1.12
8 4
4
10100
10130
29.7
25.2
1.25
1.02
81
75
Conclusions
The object of our work has been to review existing models
and collect the parameters which have been measured to help
the reader choose a simple but adequate model for the desired
application.
Most of the models clinically employed at present are single
pool models based on the assumptions that toxins are uniformly
distributed throughout body tissues [9, 39], and that mass
transport between body compartments is fast compared with
the rate of removal by dialysis-related techniques [301. The
single pool model suffices for the description of urea kinetics
and has in this role proved its worth in practice [35J.
The two pool model is appropriate and necessary for the
simulation of creatinine kinetics. It is also suitable for describ-
ing the kinetics during dialysis of uric acid, vitamin B12, and
inulin, as their transcapillary transfer coefficients are very high,
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Table 9. Patient no. 6: Hemodiafiltration (HDF): 3 x 210 mm/week
residual renal clearance: 0 mI/mm; dry body weight, 61.0 kg
Day HDF
Time
mm
Urea
mmoles/liter
Creatinine
mmoles/liter
Filtration
rate Figs. 5
mi/mm and 6
1 1
1
1
1
0
30
190
210
275
320
42.0
30.3
18.2
15.0
15.3
16.7
1.27
0.92
0.61
0.57
0.65
0.72
82
72
61
57
2 1760 25.6 0.97
3 2
2
2
2
2
2820
2850
3010
3040
3085
3130
32.0
23.1
13.0
11.3
12.2
12.3
1.08
0.80
0.53
0.50
0.55
0.63
80
74
56
54
4 3860 20.3 0.91
5 3
3
3
3
5520
5550
5710
5740
5785
5830
27.2
21.9
11.2
10.4
11.9
12.2
1.03
0.81
0.49
0.47
0.54
0.58
88
83
59
59
6 7250 19.2 0.83
7 8675 25.9 1.00
8 4
4
9885
9915
33.7
24.1
1.18
1.04
87
75
Fig. 6. Creatinine concentration (according to Fig. 5) over two treat-
ment intervals.
• Control of electrolyte concentrations [45]
• Influence of sodium balance on the volumes of fluid com-
partments [45]
• Modeling of urea and protein catabolism [46]
• Heparin model [461
• Acetate model and acetate metabolism [46]
• Carbon dioxide mass balance [461
• Body base model [46]
Thus, models afford a basis for obtaining optimal treatment
by dialysis-related procedures.
KUNO BERNT GERHARD SPRENGER
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Ulm, West Germany
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